Marksans Pharma Limited has entered into a definitive agreement to acquire 100% of the share capital of ABCnow GmbH, a Germany based pharmaceutical company with frontend sales, marketing, and ...
NAB-CCM to initiate structured awareness programmes for stakeholders on GSDP: Shardul Nautiyal, Mumbai Wednesday, July 8, 2026, 08:00 Hrs [IST] The National Accreditation Body for ...
Vertex Pharma to buy Crinetics Pharmaceuticals for $10 billion: Boston Wednesday, July 8, 2026, 14:00 Hrs [IST] Vertex Pharmaceuticals Incorporated, a global biotechnology company ...
AP govt ends institution-wide grading; individual targets mandated for all govt medical professionals: Peethaambaran Kunnathoor, Chennai Wednesday, July 8, 2026, 13:30 Hrs [IST] I ...
Incyte completes acquisition of Vega Therapeutics, a wholly owned subsidiary of Star Therapeutics: Wilmington, Delaware Wednesday, July 8, 2026, 13:00 Hrs [IST] Incyte, a biopharm ...
Roche to present new data from its Alzheimer’s disease portfolio at AAIC 2026 in London on 12-15 July: Basel Wednesday, July 8, 2026, 12:00 Hrs [IST] Roche announced that it wil ...
Digital health platforms are transforming pregnancy monitoring in India: Kiran Meena: Our Bureau, Mumbai Wednesday, July 8, 2026, 11:45 Hrs [IST] Prenatal screening powered by art ...
J P Nadda reviews implementation of key health programmes in Kerala with state health minister K Muraleedharan: Our Bureau, Mumbai Wednesday, July 8, 2026, 11:30 Hrs [IST] Union m ...
EnteroBiotix begins patient dosing in phase 2b RISE study of EBX-102-02 in irritable bowel syndrome with constipation: Glasgow, Scotland Wednesday, July 8, 2026, 10:00 Hrs [IST] E ...
J P Nadda chairs high level meeting to strengthen support for TB Mukt Bharat Abhiyaan: Our Bureau, Mumbai Wednesday, July 8, 2026, 11:15 Hrs [IST] Union minister of health and fam ...
Beckman Coulter Diagnostics receives CE-Mark under IVDR for its Access p-Tau217 assay: Brea, California Wednesday, July 8, 2026, 11:00 Hrs [IST] Beckman Coulter Diagnostics, a glo ...
UK MHRA approves Incyte Biosciences’ retifanlimab to treat advanced Merkel cell skin cancer: United Kingdom Wednesday, July 8, 2026, 09:00 Hrs [IST] The Medicines and Healthcare ...